This is an exceptional opportunity for your business to play a vital role in advancing cancer research. By applying for this grant funding, you can support the development and validation of innovative technologies that improve the quality of biological samples used in critical cancer studies. Your project could contribute to breakthroughs in early detection, treatment, and addressing cancer health disparities.

With no strict rules on revenue or employee count, this program opens its doors to a diverse range of businesses, making it easier for you to get involved. The funding can help you overcome initial challenges and propel your ideas into impactful solutions. Being approved provides not only financial support but also validates your technology's potential, setting you up for success in the ever-evolving landscape of cancer research.

Additionally, we understand that time is precious for busy business owners like you. This program is designed to be straightforward, making it easier to navigate the application process and focus on what matters most—enhancing your innovations and contributing to meaningful advancements in healthcare.

This program offers grant funding specifically designed for exploratory research projects. Grants do not require repayment, making this an excellent opportunity to secure funding without the added pressure of debt.

Eligible Expenses

The funds can be used for various eligible expenses, including:

• Development of innovative technologies.
• Tools and instrumentation focused on preserving sample integrity.
• Associated methods for quality assessment and control.
• Research activities related to cancer biology, early detection, and clinical diagnosis.

Exclusions and Fees

It’s important to note that funds cannot be used for:

• General business operating expenses unrelated to research activities.
• Any expenses that do not directly impact the development of technologies or methods for biospecimen quality.

Currently, there are no fees associated with this program. You can focus on your research and innovation without worrying about hidden costs.

• Location: Available across the country.
• Sectors: Open to all sectors.
• Legal Structure: All legal structures are applicable.
• Profit Structure: All profit structures are applicable.
• Minimum Employees: No minimum employee requirement.
• Maximum Employees: No maximum employee requirement.
• Minimum Company Revenue: No minimum revenue qualification.
• Maximum Company Revenue: No maximum revenue qualification.

Disqualifications:

• Clinical Trials: R33 applications are not allowed for clinical trials.

This program offers an exciting chance for your business to engage in exploratory research that focuses on developing new technologies for improving the quality of samples used in cancer research. If you've developed a promising idea or technology that could enhance how biospecimens are collected and stored, this funding can help you take that idea further. It empowers you to tackle challenges related to sample integrity and ensure your innovations have a positive impact on cancer research and clinical care.

You can apply for grant funding that supports the validation of technologies that have overcome initial feasibility challenges. The aim is to create tools, devices, or methods that increase the quality and usability of biological samples. This can accelerate research in crucial areas like cancer biology, early detection, and treatment, helping you contribute to advancements that matter.

The best part? There are no strict rules regarding revenue, employee count, or legal structures, making this opportunity available to a wide range of businesses. If your work is geared towards addressing the complexities of cancer research, this program could be a game-changer for you.